Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue 1, 2002, Pages 23-29

  Singh, A ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Bar test; Carbidopa; Catatonia; L DOPA; Nitecapone; Reserpine; Rota rod; Selegeline

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METIROSINE; MONOAMINE OXIDASE B INHIBITOR; NITECAPONE; RESERPINE; SELEGILINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATATONIA; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG POTENTIATION; FEMALE; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE;

ALPHA-METHYLTYROSINE; ANIMALS; ANTIPARKINSON AGENTS; CATATONIA; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; INJECTIONS, INTRAPERITONEAL; LEVODOPA; MALE; MICE; MOTOR ACTIVITY; PENTANONES; RESERPINE; SELEGILINE;

EID: 0036200212     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2002.24.1.677124     Document Type: Article

References (15)

1. The etiology of Parkinson's disease with emphasis on the MPTP story
2. Effect of nigral aid raphe lesions on catechol-O-methyltransferase and monoamine activities in the rat striatum
3. Pharmacological management of Parkinsonism and other movement disorders
4. Parkinson's disease (review). Second of two parts
5. Catechol-O-methyl transferase (COMT): Biochemistry, molecular pharmacology, pharmacology and clinical efficacy of the new selective COMT inhibitors
6. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity
7. A note on a simple apparatus for detecting neurological deficits in rats and mice
8. Dual effects of L-3,4-Dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: Evidence that behaviour is dopamine independent
9. 2 receptor stimulation by L-DOPA
10. Dopamine Agonist
11. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine treated rats
12. Neuroprotective therapies
13. MAO-B inhibitors: Multiple roles in the therapy of neurodegenerative disorders?
14. Selegeline monotherapy in the treatment of Parkinson's disease
15. Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase